[1]李丽华a,史春艳b,张 欢a,等.老年2型糖尿病患者血清USP14和GRB2水平与下肢血管病变的相关性研究[J].现代检验医学杂志,2025,40(02):140-144.[doi:10.3969/j.issn.1671-7414.2025.02.026]
 LI Lihuaa,SHI Chunyanb,ZHANG Huana,et al.Study on the Correlation between Serum USP14 and GRB2 Levels and Vascular Lesions of the Lower Limbs in Elderly Patients with T2DM[J].Journal of Modern Laboratory Medicine,2025,40(02):140-144.[doi:10.3969/j.issn.1671-7414.2025.02.026]
点击复制

老年2型糖尿病患者血清USP14和GRB2水平与下肢血管病变的相关性研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第40卷
期数:
2025年02期
页码:
140-144
栏目:
论著
出版日期:
2025-03-15

文章信息/Info

Title:
Study on the Correlation between Serum USP14 and GRB2 Levels and Vascular Lesions of the Lower Limbs in Elderly Patients with T2DM
文章编号:
1671-7414(2025)02-140-05
作者:
李丽华a史春艳b张 欢a柴雪妍a
(北京核工业医院 a. 内分泌科;b. 检验科,北京 102413)
Author(s):
LI LihuaaSHI ChunyanbZHANG HuanaCHAI Xueyana
(a. Department of Endocrinology;b. Department of Clinical Laboratory,Beijing Nuclear Industry Hospital,Beijing 102413,China)
关键词:
2 型糖尿病泛素特异性蛋白酶14生长因子受体结合蛋白2下肢血管病变
分类号:
R587.1;R392.11
DOI:
10.3969/j.issn.1671-7414.2025.02.026
文献标志码:
A
摘要:
目的 探讨老年2 型糖尿病(T2DM)患者血清泛素特异性蛋白酶14(USP14)和生长因子受体结合蛋白2(GRB2)水平与下肢血管病变(LEAD)的相关性。方法 选取北京核工业医院2020 年7 月~ 2023 年8 月收治的老年T2DM 患者153 例,根据有无LEAD 分为病变组(n=64)和非病变组(n=89);另选取同期与老年T2DM 患者年龄相匹配的153 例健康体检志愿者作为对照组。采用酶联免疫吸附法(ELISA)检测患者血清USP14 和GRB2 水平。多因素Logistic 回归分析影响T2DM 患者LEAD 发生的因素;受试者工作特征曲线(ROC)分析老年T2DM 患者USP14,GRB2 水平对发生LEAD 的诊断价值。结果 与对照组相比,病变组和非病变组中血清USP14(8.56±1.57ng/ml,6.34±1.27ng/ml vs 4.23±1.02ng/ml),GRB2 水平(7.45±1.56ng/ml,5.23±1.12ng/ml vs 3.19±0.78ng/ml)明显增加,差异具有统计学意义(q=33.555,18.259;37.326,19.960,均P < 0.05)。A 级、B 级和C 级血清USP14(7.14±1.31ng/ml,8.67±1.52ng/ml,9.98±2.01ng/ml),GRB2(6.31±1.25ng/ml,7.47±1.58ng/ml,8.69±1.74ng/ml)水平依次增加,差异具有统计学意义(F=14.754,11.404,均P < 0.05)。多因素Logistic 回归分析结果显示,USP14,GRB2,TC,TG,LDL-C 和HbA1c 均是影响老年T2DM 患者LEAD 发生的影响因素(Wald χ2=11.618 ~ 41.458,均P < 0.05);ROC曲线结果显示,血清USP14 和GRB2 联合诊断LEAD的曲线下面积(AUC)高于USP14 和GRB2 单独诊断(Z=2.706,3.124,均P < 0.05)。结论 USP14 和GRB2 在老年T2DM 并发LEAD 患者血清中均呈高表达水平,随LEAD 分级增加而升高,可作为诊断老年T2DM 并发LEAD 的血清标志物,两者联合检测效能更佳。
Abstract:
Objective To investigate the correlation between serum ubiquitin-specific protease 14 (USP14) and growth factor receptor binding protein 2 (GRB2) levels and vascular lesions of the lower limbs (LEAD) in elderly patients with type 2 diabetes (T2DM). Methods 153 elderly T2DM patients admitted to Beijing Nuclear Industrial Hospital from July 2020 to August 2023 were selected and divided into lesion group (n=64) and non-lesion group (n=89) according to the presence or absence of LEAD, in addition and 153 healthy volunteers who matched the age of elderly T2DM patients in the same period were selected as the control group. Enzyme-linked immunosorbent assay (ELISA) was used to detect serum USP14 and GRB2 levels in patients. Multifactorial Logistic regression was used to analyze the factors affecting the occurrence of LEAD in patients with elderly T2DM. Receiver operating curve (ROC) analysis of USP14 and GRB2 levels in elderly T2DM patients for the diagnostic value of LEAD occurrence. Results Compared with the control group, serum USP14(8.56±1.57ng/ml, 6.34±1.27ng/ml vs 4.23±1.02ng/ml), GRB2 levels(7.45±1.56ng/ml,5.23±1.12ng/ml vs 3.19±0.78ng/ml)were significantly increased in the diseased and non-diseased groups, and the differences were statistically significant (q=33.555, 18.259;37.326,19.960,all P < 0.05). Class A, B and C serum USP14(7.14±1.31ng/ml,8.67±1.52ng/ml,9.98±2.01ng/ ml), GRB2 levels(6.31±1.25ng/ml,7.47±1.58ng/ml,8.69±1.74ng/ml) increased in that order, and the differences were all statistically significant (F=14.754, 11.404, all P < 0.05). Multifactorial Logistic regression analysis showed that USP14 , GRB2, TC, TG,LDL-C and HbA1c were all influencing factors affecting the occurrence of LEAD in patients with T2DM (Wald χ2=11.618 ~ 41.458, all P< 0.05). The results of the ROC curve showed that the area under the curve (AUC) of the combined diagnosis of LEAD by serum USP14 and GRB2 was greater than that of USP14 and GRB2 diagnosed alone (Z=2.706, 3.124, all P<0.05). Conclusion USP14 and GRB2 were both highly expressed in the serum of patients with elderly T2DM combined with LEAD, which increased with the increase of LEAD grade, and can be used as serum markers for the diagnosis of elderly T2DM combined with LEAD, and the efficacy of the combined detection of the two is better.

参考文献/References:

[1] TINAJERO M G, MALIK V S. An update on the epidemiology of type 2 diabetes: a global perspective[J]. Endocrinology and Metabolism Clinics of North America, 2021, 50(3): 337-355.
[2] WEI Jiahua, TIAN Jiaxing, TANG Cheng, et al. The influence of different types of diabetes on vascular complications [J]. Journal of Diabetes Research, 2022, 2022: 3448618.
[3] BUSO G, ABOYANS V, MAZZOLAI L. Lower extremity artery disease in patients with type 2 diabetes[J]. European Journal of Preventive Cardiology, 2019, 26(2_suppl): 114-124.
[4] FU Yuan, QIU Junxiong, WU Jianhua, et al. USP14-mediated NLRC5 upregulation inhibits endothelial cell activation and inflammation in atherosclerosis[J].Biochimica et Biophysica Acta-molecular and Cell Biology of Lipids, 2023, 1868(5): 159258.
[5] KAMOSHITA K, ISHII K A, TAHIRA Y, et al. Insulin suppresses ubiquitination via the deubiquitinating enzyme ubiquitin-specific protease 14, independent of proteasome activity in H4IIEC3 hepatocytes[J].the Journal of Pharmacology and Experimental Therapeutics, 2023, 385(1): 5-16.
[6] DONG Yuyan, LIU Juxiang, MA Jing, et al. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus [J].Frontiers in Endocrinology (Lausanne), 2022, 13:963191.
[7] 中华医学会糖尿病学分会,中华医学会感染病学分会,中华医学会组织修复与再生分会. 中国糖尿病足防治指南(2019 版)(Ⅰ)[J]. 中华糖尿病杂志,2019,11(2):92-108. Chinese Diabetes Society,Chinese Society of Infectious Diseases,Chinese Society for Tissue Repair and Regeneration. Chinese guideline on prevention and management of diabetic foot (2019 edition) (I) [J].Chinese Journal of Diabetes Mellitus, 2019,11(2): 92-108.
[8] 中华医学会糖尿病学分会,朱大龙. 中国2 型糖尿病防治指南(2020 年版)( 上)[J]. 中国实用内科杂志,2021,41(8):668-695 Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)(Part 1)[J]Chinese Journal of Practical Internal Medicine,2021,41(8):668-695
[9] 中国医师协会超声医师分会. 血管超声检查指南[J].中华超声影像学杂志,2009,18(11):993-1012. Ultrasound Physician Branch of Chinese Medical Association. Guidelines for vascular ultrasonography[J].Chinese Journal of Ultrasonography, 2009, 18(11): 993-1012.
[10] 贺炜, 刘泓键, 易艳霞, 等. 血清骨生成诱导因子及miR-22-3p 表达水平对2 型糖尿病肾病早期诊断价值研究[J]. 现代检验医学杂志,2023,38(2):37-42. HE Wei, LIU Hongjian, YI Yanxia, et al. Value of serum osteoinductive factor and miR-22-3p expression in the early diagnosis of type 2 diabetic nephropathy[J]. Journal of Modern Laboratory Medicine, 2023, 38(2): 37-42.
[11] 陈彬琼, 胡惠蓉. 彩色多普勒超声诊断2 型糖尿病合并下肢血管病变的价值[J].糖尿病新世界,2020,23(7):188-189. CHEN Binqiong, HU Huirong. The value of colour Doppler ultrasound in the diagnosis of type 2 diabetes mellitus combined with lower limb vasculopathy[J].Diabetes New World Magazine, 2020, 23(7): 188-189.
[12] 王晶, 熊华花, 邓水平, 等. 彩色多普勒超声诊断不同病程老年2 型糖尿病下肢血管病变的临床价值及与血清ET, NO 的关系研究[J]. 现代生物医学进展,2021,21(16):3064-3068. WANG Jing, XIONG Huahua, DENG Shuiping, et al. The clinical value of color doppler ultrasonography in the diagnosis of lower extremity vascular diseases in elderly type 2 diabetes mellitus with different course and its relationship with serum ET and NO[J]. Progress in Modern Biomedicine, 2021, 21(16): 3064-3068.
[13] HE Futao, FU Xiaolin, LI Mohan, et al. USP14 regulates ATF2/PIK3CD axis to promote microvascular endothelial cell proliferation, migration, and angiogenesis in diabetic retinopathy[J]. Biochemical Genetics, 2023, 61(5): 2076-2091.
[14] 李佳旺, 王丰. 蛋白酶体相关去泛素化酶USP14 的研究进展[J]. 生命科学仪器,2019,17(4):22-33. LI Jiawang, WANG Feng. Advances in research on the proteasome-associated deubiquitinating enzyme Usp14[J].Life Science Instruments, 2019, 17(4): 22-33.
[15] LIU Bin, ZHANG Zhijian, HU Yanyun, et al. Sustained ER stress promotes hyperglycemia by increasing glucagon action through the deubiquitinating enzyme USP14[J]. Proceedings of the National Academy of Sciences of the U S A, 2019, 116(43): 21732-21738.
[16] ZHANG Zhiwen, GUO Quan, MA Chao, et al. USF1 transcriptionally activates USP14 to drive atherosclerosis by promoting EndMT through NLRC5/Smad2/3 axis[J]. Molecular Medicine, 2024, 30(1): 32.
[17] 罗悦玲, 黄彬, 曹聪, 等. 老年2 型糖尿病患者血清ANGPTL4, Betatrophin, Vaspin 水平与血糖?血脂及下肢血管病变的关系研究[J]. 现代生物医学进展,2021,21(10):1863-1867, 1853. LUO Yuel ing, HUANG Bin, CAO Cong, et al. Study on the relationship between serum ANGPTL4,betatrophin,vaspin levels and blood glucose,blood lipids and lymphatic vessel density in elderly patients with type 2 diabetes[J]. Progress in Modern Biomedicine, 2021, 21(10): 1863-1867, 1853.
[18] FASELIS C, KATSIMARDOU A, IMPRIALOS K, et al. Microvascular complications of type 2 diabetes mellitus[J]. Current Vascular Pharmacology, 2020, 18(2): 117-124.
[19] FU Shuhua, ZHENG Yunyao, SUN Yawen, et al. Suppressing long noncoding RNA OGRU ameliorates diabetic retinopathy by inhibition of oxidative stress and inflammation via miR-320/USP14 axis [J]. Free Radical Biology & Medicine, 2021, 169: 361-381.
[20] YE Meng, GUO Xiangjiang, KAN Kejia, et al. Loss of GRB2 associated binding protein 1 in arteriosclerosis obliterans promotes host autophagy [J]. Chinese Medical Journal (England), 2020, 134(1): 73-80.
[21] LI Yang, DING Xiaoming, TIAN Xiaohui, et al. Islet transplantation modulates macrophage to induce immune tolerance and angiogenesis of islet tissue in type I diabetes mice model[J]. Aging, 2020, 12(23): 24023-24032.
[22] LIU Hongbin, LI Xiaoliang, YAN Guobei, et al. Knockdown of USP14 inhibits PDGF-BB-induced vascular smooth muscle cell dedifferentiation via inhibiting mTOR/P70S6K signaling pathway[J]. RSC Advances, 2019, 9(63): 36649-36657.
[23] KONDREDDY V, KESHAVA S, DAS K, et al. The gab2– MALT1 axis regulates thromboinflammation and deep vein thrombosis[J]. Blood, 2022, 140(13): 1549-1564.
[24] GUO Junxia, LI Jianhua, ZHANG Junbiao, et al. LncRNA PVT1 knockdown alleviated ox-LDL-induced vascular endothelial cell injury and atherosclerosis by miR-153-3p/GRB2 axis via ERK/p38 pathway[J]. Nutrition, Metabolism, and Cardiovascular Diseases, 2021, 31(12): 3508-3521.

相似文献/References:

[1]韩登科,房绮梅,谢晋烨,等.2 型糖尿病并发高血压患者血清Fetuin B 水平检测及与Hcy 浓度的相关性研究[J].现代检验医学杂志,2020,35(02):24.[doi:10.3969 / j.issn.1671-7414.2020.02.008]
 HAN Deng-ke,FANG Qi-mei,XIE Jin-ye,et al.Serum Fetuin B Level in Patients with Type 2 Diabetes Mellitus Complicated withHypertension and Its Correlation with Hcy Concentration were Investigated[J].Journal of Modern Laboratory Medicine,2020,35(02):24.[doi:10.3969 / j.issn.1671-7414.2020.02.008]
[2]刘肖瑛,林佩娜,欧阳伟庆,等.2 型糖尿病患者血清sdLDL 和脂类水平及相关性分析[J].现代检验医学杂志,2020,35(03):58.[doi:10.3969/j.issn.1671-7414.2020.03.014]
 LIU Xiao-ying,LIN Pei-na,OUYANG Wei-qing,et al.Analysis of Serum sdLDL and Lipid Levels and Their Correlation in Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2020,35(02):58.[doi:10.3969/j.issn.1671-7414.2020.03.014]
[3]洪雄新,李观强,杨 辉,等.2 型糖尿病患者ABCA1 R219K 基因多态性分布及其与血脂水平的相关性研究[J].现代检验医学杂志,2020,35(04):14.[doi:10.3969/j.issn.1671-7414.2020.04.004]
 HONG Xiong-xin,LI Guan-qiang,YANG Hui,et al.Study on Distribution of ABCA1 R219K Gene Polymorphism and Its Correlation with Blood Lipid Levels for Type 2 Diabetes Mellitus Patients[J].Journal of Modern Laboratory Medicine,2020,35(02):14.[doi:10.3969/j.issn.1671-7414.2020.04.004]
[4]骆时木,叶宇宸,欧阳航,等.福建省泉州地区汉族人群TCF7L2 rs11196205基因多态性与T2DM 的相关性研究[J].现代检验医学杂志,2020,35(04):22.[doi:10.3969/j.issn.1671-7414.2020.04.006]
 LUO Shi-mu,YE Yu-chen,OUYANG Hang,et al.Correlation between TCF7L2 rs11196205 Gene Polymorphism and Onset Risk of T2DM in Han Population of Quanzhou, Fujian Province[J].Journal of Modern Laboratory Medicine,2020,35(02):22.[doi:10.3969/j.issn.1671-7414.2020.04.006]
[5]杨莉婷,陈 翠,蒋兴亮.2 型糖尿病患者血清残余胆固醇水平与超敏C 反应蛋白表达的相关性研究[J].现代检验医学杂志,2020,35(04):45.[doi:10.3969/j.issn.1671-7414.2020.04.011]
 YANG Li-ting,CHEN Cui,JIANG Xing-liang.Association between Serum Remnant Cholesterol Levels and Expression of High Sensitive C-reactive Protein in Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(02):45.[doi:10.3969/j.issn.1671-7414.2020.04.011]
[6]张海霞a,郭 杰a,袁 宁a,等.老年健康体检人群外周血红细胞分布宽度与糖化血红蛋白A1c 的相关性研究[J].现代检验医学杂志,2020,35(04):65.[doi:10.3969/j.issn.1671-7414.2020.04.016]
 ZHANG Hai-xia a,GUO Jiea,YUAN Ninga,et al.Association of Peripheral Blood Red Blood Cell Distribution Width with Glycated Hemoglobin A1c in the Healthy Elderly Population for Check-ups[J].Journal of Modern Laboratory Medicine,2020,35(02):65.[doi:10.3969/j.issn.1671-7414.2020.04.016]
[7]张 艳a,刘 翔a,李鸿钏a,等.血清脂蛋白磷脂酶A2 和血浆抗凝血酶Ⅲ对2 型糖尿病患者发生缺血性脑卒中风险的评估价值[J].现代检验医学杂志,2020,35(04):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
 ZHANG Yana,LIU Xianga,LI Hong-chuana,et al.Evaluation Value of Serum Lipoprotein-Associated Phospholipase A2 and Plasma Antithrombin Ⅲ on the Risk of Ischemic Stroke in Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(02):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
[8]张 凯,李全双,程 星.2 型糖尿病患者血清低清蛋白水平对糖化清蛋白检测结果的影响[J].现代检验医学杂志,2020,35(04):126.[doi:10.3969/j.issn.1671-7414.2020.04.032]
 ZHANG Kai,LI Quan-shuang,CHENG Xing.Effect of Serum Low Albumin Level on the Detection of Glycosylated Albumin in Patients with Type 2 Ddiabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(02):126.[doi:10.3969/j.issn.1671-7414.2020.04.032]
[9]刘倩倩,鲁作华,王 星,等.血浆D- 二聚体在2 型糖尿病患者早期肾损伤中的应用价值[J].现代检验医学杂志,2020,35(04):134.[doi:10.3969/j.issn.1671-7414.2020.04.034]
 LIU Qian-qian,LU Zuo-hua,WANG Xing,et al.Application Value of Serum D-Dimer in Early Kidney Injury in Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2020,35(02):134.[doi:10.3969/j.issn.1671-7414.2020.04.034]
[10]欧阳清慧,王 冰,杨自力,等.四川省绵阳地区慢性丙型肝炎患者继发2 型糖尿病危险因素分析[J].现代检验医学杂志,2020,35(04):151.[doi:10.3969/j.issn.1671-7414.2020.04.038]
 OUYANG Qing-hui,WANG Bing,YANG Zi-li,et al.Analysis of Risk factors of Chronic Hepatitis C Complicated with Type 2 Diabetes Mellitus in Mianyang of Sichuan[J].Journal of Modern Laboratory Medicine,2020,35(02):151.[doi:10.3969/j.issn.1671-7414.2020.04.038]

备注/Memo

备注/Memo:
作者简介:李丽华(1982-)女,大专,主治医师,研究方向:糖尿病,E-mail:t31hrw@163.com。
通讯作者:柴雪妍(1978-)女,本科,副主任医师,研究方向:糖尿病及并发症,E-mail:b81wny@163.com。
更新日期/Last Update: 2025-03-15